Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplan¬tation

Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplan¬tation

Objective: To evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic HSCT recipients.Patients and Method: In this single-center study, 111 consecutive febrile episodes in 104 neutropenic HSCT recipients with a mean age of 26 years were randomized to treatment ei...

Full description

Bibliographic Details
Main Authors: Kani C., Mousavi A., Iravani M, Alimoghaddam K, Bahar B, Jahani M, Ghavamzadeh A
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2005-07-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
neutropenia Monotherapy Hematopoietic stem cell transplantation Randomized trial
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4536.pdf&manuscript_id=4536

Internet

http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4536.pdf&manuscript_id=4536

Similar Items